Design-Zyme LLC
Lawrence, KS
- UEI
- RM33XDX5RRG4
- CAGE
- 7KSG8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 4950 Research Park Way, Lawrence, KS 66047, USA
- Website
- design-zyme.com
- Founded
- 2024
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of covalently bound hyaluronic acid as an adjuvant for multivalent lyme disease vaccine | National Institute of Allergy and Infectious Diseases | $2,999,999 | |
| A cortisol sensing enzyme system: a new platform utilizing dehydrogenases in biosensors | National Institute of General Medical Sciences | $252,126 | |
| In vitro enzyme glycosylation: a new platform for enzyme stabilization | National Institute of General Medical Sciences | $251,966 | |
| Development of a wearable band-aid biosensor system for alcohol monitoring | National Institute on Alcohol Abuse and Alcoholism | $374,747 | |
| Isolation and identification of prebiotic nutrient components | National Institute on Aging | $149,995 |
About Design-Zyme LLC
Design-Zyme LLC is a for-profit limited liability company registered in the System for Award Management (SAM.gov) since March 14, 2016, with registration valid through December 4, 2025. The company appears to be a biotechnology-focused small business that specializes in developing innovative enzyme and biosensor technologies for medical and scientific applications. Based on its federal award history, Design-Zyme LLC demonstrates expertise in creating advanced enzyme systems, biosensors, and vaccine-related biotechnological solutions.
The company's federal contract work is exemplified by a significant $2,999,999 SBIR Phase II contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID). This contract, competitively awarded under the small business set-aside program, focuses on developing a novel approach to Lyme disease vaccine technology. Specifically, the contract involves creating a covalently bound hyaluronic acid adjuvant for a multivalent Lyme disease vaccine, with a project completion date of September 29, 2027. The contract demonstrates Design-Zyme LLC's capability to engage in advanced biomedical research and development for federal civilian agencies, with a particular emphasis on innovative vaccine and immunological technologies.
Design-Zyme LLC has also secured multiple federal grants from the National Institute of General Medical Sciences, highlighting its research capabilities in enzyme and biosensor technologies. These grants include a project developing a cortisol sensing enzyme system utilizing dehydrogenases in biosensors (R43GM137652) and another exploring in vitro enzyme glycosylation as a platform for enzyme stabilization (R43GM137719). Both grants were relatively short-term project grants, with completion dates in 2021 and 2022 respectively. These awards underscore the company's expertise in advanced enzymatic research, biosensor development, and innovative approaches to enzyme modification and stabilization, positioning Design-Zyme LLC as a specialized biotechnology research entity with strong capabilities in creating advanced scientific platforms and solutions.
SBA capabilities narrative
Design-Zyme is involved in the production, modification, and testing of enzymes for use in health monitoring devices.
Quick answers
What is Design-Zyme LLC's UEI?
Design-Zyme LLC's Unique Entity ID (UEI) in SAM.gov is RM33XDX5RRG4.
What is Design-Zyme LLC's CAGE code?
Design-Zyme LLC's CAGE code is 7KSG8.
What is Design-Zyme LLC's primary NAICS code?
Design-Zyme LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Design-Zyme LLC located?
Design-Zyme LLC's physical address in SAM.gov is 4950 Research Park Way, Lawrence, KS 66047, USA.
Is Design-Zyme LLC registered in SAM.gov?
Yes. Design-Zyme LLC's SAM.gov registration is active through January 16, 2027.
What is Design-Zyme LLC's most recent federal award?
Design-Zyme LLC's most recent federal contract award is Development of covalently bound hyaluronic acid as an adjuvant for multivalent lyme disease vaccine (75N93024C00016), from National Institute of Allergy and Infectious Diseases, on September 30, 2024.
On GovTribe
See Design-Zyme LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors